Nupotential, Inc.

Baton Rouge, LA 70803

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $2.32MM
First Award Date 09/15/04
Most Recent Award Date 08/01/11

Key Personnel

Last Name Name Awards Contact
Hicock Kevin Hicock 1
Floyd Zelpha Elizabeth Floyd 2
Staszkiewicz Jaroslaw Staszkiewicz 2
Leno Gregory Leno 1
Power Rachel Power 3
Rim Jong S Rim 2
Snodgrass Ralph Snodgrass 2

9 Awards Won

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 08/01/11 - 01/31/13

DESCRIPTION (provided by applicant): Direct reprogramming of somatic cells to induced pluripotent stem (iPS) cells has been demonstrated by viral transduction of exogenous transcription factors. These initial demonstrations have provided valuable insight into molecular mechanisms of somatic cell reprogramming and raised the possibility that alte...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-249
Budget: 06/01/11 - 05/31/13

DESCRIPTION (provided by applicant): NuPotential will use SBIR funds to improve a patent pending method to reprogram cells using a novel small molecule library. Reprogrammed cells generated using this improved method will be referred to as NuPiPSsm" cells. In addition, NuPotential will partner with VistaGen, Inc., to differentiate NuPiPSsm" ce...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 09/18/10 - 07/31/11

DESCRIPTION (provided by applicant): Direct reprogramming of somatic cells to induced pluripotent stem (iPS) cells has been demonstrated by viral transduction of exogenous transcription factors. These initial demonstrations have provided valuable insight into molecular mechanisms of somatic cell reprogramming and raised the possibility that alte...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-249
Budget: 07/15/10 - 05/31/11

DESCRIPTION (provided by applicant): NuPotential will use SBIR funds to improve a patent pending method to reprogram cells using a novel small molecule library. Reprogrammed cells generated using this improved method will be referred to as NuPiPSsm" cells. In addition, NuPotential will partner with VistaGen, Inc., to differentiate NuPiPSsm" ce...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 06/01/10 - 05/31/12

DESCRIPTION (provided by applicant): NuPotential, Inc. will use NIH STTR funds to generate and validate human Oct-4 gene-targeted reporter cell lines that will provide superior predictive indexing of gene transcription for the identification of efficient reprogramming-competent epi-drugs. To accomplish this, NuPotential will partner with Dr. Gre...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-08-051
Budget: 09/30/09 - 12/31/11

DESCRIPTION (provided by applicant): NuPotential will use NIH STTR funds to develop and validate a novel epigenetic-based in vitro system for reprogramming bovine donor cells to improve the efficiency of somatic cell nuclear transfer (SCNT). To accomplish this, NuPotential will alter chromatin epigenetic marks to induce key pluripotency genes a...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/06 - 06/30/08

DESCRIPTION (provided by applicant): Infigen will use SBIR grant support to develop a model for evaluating the molecular events associated with cellular reprogramming that enables early determination of a cell's probability of developing into a desired organism or tissue. No such model has been reported to date, impeding rational approaches to d...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/05 - 06/30/06

DESCRIPTION (provided by applicant): Infigen will use SBIR grant support to develop a model for evaluating the molecular events associated with cellular reprogramming that enables early determination of a cell's probability of developing into a desired organism or tissue. No such model has been reported to date, impeding rational approaches to d...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/04 - 03/14/05

DESCRIPTION (provided by applicant): Infigen will use SBIR grant support to develop a model for evaluating the molecular events associated with cellular reprogramming that enables early determination of a cell's probability of developing into a desired organism or tissue. No such model has been reported to date, impeding rational approaches to d...